about
Direct oral anticoagulant use in nonvalvular atrial fibrillation with valvular heart disease: a systematic reviewEffect of diseases on response to vitamin K antagonists.Ivabradine: A Review of Labeled and Off-Label Uses.Pharmacologic Treatment of Alcoholic Hepatitis: Examining Outcomes Based on Disease Severity Stratification.Edoxaban Use in Nonvalvular Atrial Fibrillation With Valvular Heart Disease-Insights from ENGAGE AF-TIMI 48.Comparison of the Safety and Effectiveness of Apixaban versus Warfarin in Patients with Severe Renal Impairment: An Alternative Viewpoint.Asthma as a Comorbidity in Hospitalized Patients: A Potential Missed Opportunity to Intervene.Hemolytic Anemia Induced by Pegloticase Infusion in a Patient With G6PD Deficiency
P50
Q28071807-345D0451-5D77-4C34-B70E-F189E35B6C21Q38676493-DA3CC727-B13A-49C1-92CB-AE08F6D6683CQ38894220-D5DE2E80-3BA9-4EEA-BD07-A3D54952C86EQ39047901-26C52821-2569-4BC0-B5F1-E184C12B2AC9Q48252586-827DDBD9-AB82-4994-B5C9-69634C3AAEE8Q48351747-26610999-8C68-4EA4-AA14-8ADB5D73C897Q51534914-4A236587-7B5D-42D9-AA1B-8BAC9ED4AA0DQ87350183-7581E67B-5B41-44B6-9F8E-EF758C138E78
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Ryan E Owens
@en
Ryan E Owens
@nl
type
label
Ryan E Owens
@en
Ryan E Owens
@nl
prefLabel
Ryan E Owens
@en
Ryan E Owens
@nl
P31
P496
0000-0002-6643-419X